Compugen CGEN 深 沪
等待开盘 10-20 09:30:00 美东时间
1.875
-0.075
-3.85%
华盛通- 最 高2.00
- 今 开2.00
- 成交量 67.89万股
- 最 低 1.81
- 昨 收 1.95
- 总市值 1.75亿
- 52周最高 2.66
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.13
- 委 比 -36.73%
- 总股本 9353.54万
- 历史最高 19.90
- 量 比 0.64
- 振 幅 9.74%
- 历史最低 0.51
- 每 手 1
- 风险率 0.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多阿斯利康携四项重磅研究首发数据亮相ESMO，彰显重新定义癌症治疗的雄心
（来源：氨基观察） DESTINY-Breast11与DESTINY-Breast05两项研究入选主席研讨会（Presidential Symposium）...
10-15 12:05
Compugen Publishes Pooled Data Showing COM701 Activity in Platinum-Resistant Ovarian Cancer Ahead of ESMO Presentation
Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that pooled analysis of
10-13 19:10
Compugen to Present at SITC 2025
HOLON, Israel, Oct. 6, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...
10-06 19:00
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
NEW YORK, NY / ACCESS Newswire / September 30, 2025 / Investor Summit Group is ...
10-01 01:00
Compugen to Present Research at the Single Cell Genomics 2025 Conference
HOLON, ISRAEL, Sept. 8, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discover...
09-08 19:00
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Compugen Initiates Global Trial for COM701 in Ovarian Cancer
Compugen ( ($CGEN) ) has shared an update. On July 21, 2025, Compugen Ltd. anno...
07-21 19:28
Compugen’s Q1 2025: Clinical Progress and Financial Stability
Compugen ( ($CGEN) ) has released its Q1 earnings. Here is a breakdown of the i...
05-20 11:56
Compugen GAAP EPS of -$0.08, revenue of $2.3M
Compugen press release (NASDAQ:CGEN): Q1 GAAP EPS of -$0.08. Revenue of $2.3M (-11.5% Y/Y). Cash: As of March 31, 2025, Compugen had approximately $103.7 million in cash, cash equivalents, short-term ...
05-19 19:13
Compugen Q1 EPS $(0.08) Misses $(0.06) Estimate, Sales $2.28M Miss $3.70M Estimate
Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is unchanged from the same period last year. The company reported
05-19 19:01
